Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.

他のバージョン（1件）を表示する

Many anticancer therapies, including ionizing radiation (IR), cause cytotoxicity through generation of DNA double-strand breaks (DSB). Delivery of therapeutic radionuclides to DNA DSB sites can amplify this DNA damage, for additional therapeutic gain. Herein, we report on two radiopharmaceuticals, r...

書誌詳細
主要な著者:	Cornelissen, B, Waller, A, Able, S, Vallis, K
フォーマット:	Journal article
言語:	English
出版事項:	American Association for Cancer Research 2013

類似資料

Molecular radiotherapy using cleavable radioimmunoconjugates that target eGFR and γH2AX
著者:: Cornelissen, B, 等
出版事項: (2013)

Can γH2AX be used to personalise cancer treatment?
著者:: Shah, K, 等
出版事項: (2013)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
著者:: Cornelissen, B, 等
出版事項: (2012)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
著者:: Cornelissen, B, 等
出版事項: (2012)

γH2AX expression in cytological specimens as a biomarker of response to radiotherapy in solid malignancies
著者:: Shah, K, 等
出版事項: (2015)

Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
著者:: Cornelissen, B, 等
出版事項: (2011)

Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR
著者:: Luke Yongkyu Kwon, 等
出版事項: (2024-05-01)

New radioimmunoconjugate -dota-h-r3. synthesis and radiolabeling
著者:: Denis R. Beckford Vera, 等
出版事項: (2007-01-01)

EP-2324: Non-invasive PET imaging of radiosensitive tumour regions using γH2AX-targeted immunoconjugate
著者:: Yaromina, A, 等
出版事項: (2018)

The Phosphorylated Form of the Histone H2AX (γH2AX) in the Brain from Embryonic Life to Old Age
著者:: Adalberto Merighi, 等
出版事項: (2021-11-01)

The kinetics of γ-H2AX during radiotherapy of head and neck cancer potentially allow for prediction of severe mucositis
著者:: Kazmierska Joanna, 等
出版事項: (2020-02-01)

Intracellular delivery of radioimmunoconjugates that target the cancer testis antigen, NY-ESO-1
著者:: Chu, H
出版事項: (2013)

Generation of an alpaca‐derived nanobody recognizing γ‐H2AX
著者:: Malini Rajan, 等
出版事項: (2015-01-01)

Predictive effect of γH2AX expression on the radiosensitivity of glioma
著者:: Jun-wei WANG, 等
出版事項: (2014-03-01)

In vivo Analysis of H2AX Phosphorylation Induced by γ-Radiation
著者:: Seyed Mostafa Mir, 等
出版事項: (2017-03-01)

PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
著者:: Knight, J, 等
出版事項: (2015)

On cleavability
著者:: Levine, S
出版事項: (2012)

Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
著者:: Song, L, 等
出版事項: (2017)

PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
著者:: Knight, J, 等
出版事項: (2015)

Internalising radioimmunoconjugates to target KRas cancer cells for simultaneous radio-ligand therapy and radiosensitisation
著者:: Lourenço, J
出版事項: (2024)

89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
著者:: Knight, J, 等
出版事項: (2016)

Residual γH2AX foci as an indication of lethal DNA lesions
著者:: Banuelos C Adriana, 等
出版事項: (2010-01-01)

Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.
著者:: Cornelissen, B, 等
出版事項: (2008)

Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.
著者:: Glatting, G, 等
出版事項: (2006)

Increased γ-H2A.X intensity in response to chronic medium-dose-rate γ-ray irradiation.
著者:: Takashi Sugihara, 等
出版事項: (2012-01-01)

Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery
著者:: Guanren Zhao, 等
出版事項: (2017-06-01)

DNA Damage Sensor γ-H2AX Is Increased in Preneoplastic Lesions of Hepatocellular Carcinoma
著者:: Yasunobu Matsuda, 等
出版事項: (2013-01-01)

A portable microfluidic fluorescence spectrometer device for γ-H2AX-based biological dosimetry
著者:: Pope, I, 等
出版事項: (2011)

Developable spaces and cleavability
著者:: F. CAMMAROTO, 等
出版事項: (1994-09-01)

EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.
著者:: Song, L, 等
出版事項: (2016)

Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma
著者:: Ashleigh Hull, 等
出版事項: (2022-09-01)

Development of radioimmunoconjugate for diagnosis and management of head-and-neck subclinical cancer and colorectal carcinoma
著者:: Raquel Benedetto, 等
出版事項: (2018-04-01)

ATM and SIRT6/SNF2H Mediate Transient H2AX Stabilization When DSBs Form by Blocking HUWE1 to Allow Efficient γH2AX Foci Formation
著者:: Yuko Atsumi, 等
出版事項: (2015-12-01)

Imaging DNA damage response (DDR) during oncogenesis
著者:: Cornelissen, B, 等
出版事項: (2013)

Targeting the tumour: Cell penetrating peptides for molecular imaging and radiotherapy
著者:: Kersemans, V, 等
出版事項: (2010)

Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry
著者:: Zhuoqing Chen, 等
出版事項: (2024-02-01)

PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
著者:: Deepti Sharma, 等
出版事項: (2019-12-01)

Development of a high-throughput γ-H2AX assay based on imaging flow cytometry
著者:: Younghyun Lee, 等
出版事項: (2019-08-01)

Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation
著者:: Stephanie Dobersch, 等
出版事項: (2021-02-01)

Cohesin protects genes against γH2AX Induced by DNA double-strand breaks.
著者:: Pierre Caron, 等
出版事項: (2012-01-01)